Economy · June 23, 2022

ICER 2022 Protocol “Barriers to Fair Access Assessment” – Healthcare Economist

How does ICER intend to determine whether health plans offer equitable access to pharmaceuticals? I summarized their approach last year as outlined in their white paper titled “Cornerstones of ‘Fair’ Drug Coverage: Appropriate Cost Sharing and Use Management Policies for Pharmaceuticals.” Last month, final protocol for their “Barriers to Fair Access Assessment”. Although the approach follows the previous protocol and white paper, not all criteria in this white paper are evaluated. What criteria is the ICER evaluating? Below I have summarized the criteria that ICER intends to include and exclude in the evaluation of “Correct access”.